World Needle Free Drug Delivery Market Canvassed in New RNCOS E-Services Report Now Available at MarketPublishers.com
19 May 2015 • by Natalie Aster
LONDON – The world’s needle free drug delivery sector has been gathering steam recently, providing a host of opportunities to the industry participants. Supported by favourable demographics, upward eco-financial trend, and booming awareness, the globe’s needle free drug delivery market is poised to reach a high point of its development in the offing. Additionally, factors like augmented mergers and acquisitions activity in the industry, the appearance of innovative needle free drug delivery devices such as microneedle patches and rollers, and entry of new players, are expected to further contribute to the market’s growth.
New market research report “Global Needle Free Drug Delivery Market Outlook 2020” developed by RNCOS E-Services Pvt. Ltd. covers the dynamics of the world needle free drug delivery market, which is broken down into five distinct segments: jet injectors, micro needles, transdermal patches and oral and inhalation drug delivery. It portrays a crystal clear picture of the current performance and offers the expected future outlook through to 2020. Each segment is further split into sub-segments, which are analysed in detail. The study limelights the segments that provide the maximum opportunity for growth in the global needle free drug delivery market. It includes an in-depth analysis of key drivers and trends that are expected to act as catalysts toward stimulating the industry’s development alongside stumbling blocks hampering the growth in the sector. The study also looks at the regulatory environment having a bearing on the needle free drug delivery devices in some countries. Furthermore, the research publication thoroughly examines the competitive landscape, featuring the industry leaders’ businesses, financials, weaknesses & strengths and latest developments.
Companies addressed in the study: Antares Pharma, Inc., Mylan Inc., Merck & Co., 3M (MMM), Novatis, AstraZeneca Plc, GlaxoSmithKline Plc (GSK), Sanofi, and Boehringer Ingelheim GmbH.
Global Needle Free Drug Delivery Market Outlook 2020
Published: May, 2015
Price: US$ 1,500.00
More new studies by the publisher can be found at RNCOS E-Services page.